Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.
Study Design
- 研究类型
- Other
- 研究人群
- None
- 干预措施
- Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. None
- 对照组
- None
- 主要结局
- Lactobacillus acidophilus modulates intestinal pain and induces opioid and canna
- 效应方向
- Mixed
- 偏倚风险
- Moderate
Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut-similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treatment of abdominal pain and irritable bowel syndrome.
简要概述
It is found that oral administration of specific Lactobacillus strains induced the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut—similar to the effects of morphine.
Used In Evidence Reviews
Similar Papers
PloS one · 2012
A meta-analysis of probiotic efficacy for gastrointestinal diseases.
Journal of clinical gastroenterology · 2004
Bacteriotherapy using fecal flora: toying with human motions.
Journal of clinical gastroenterology · 2012
The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Journal of clinical gastroenterology · 2004
Probiotics in the treatment of irritable bowel syndrome.
Journal of gastroenterology and hepatology · 2014
Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Journal of clinical gastroenterology · 2011